Civic Intelligence

Pharmaceutical Association of San Francisco

990 • Fiscal year 2012 • EIN 94-3174216

Jan 01, 2012 to Dec 31, 2012

San Francisco, CA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

79th percentile

0.47x

Higher debt load relative to assets than 79% of similar nonprofits.

2012 filings • 501(c)7 • $500k-$1M nonprofits • Source year 2012

Liabilities / Revenue

93rd percentile

2.88x

Higher debt load relative to revenue than 93% of similar nonprofits.

2012 filings • 501(c)7 • $500k-$1M nonprofits • Source year 2012

Net Margin

64th percentile

11%

Higher net margin than 64% of similar nonprofits.

2012 filings • 501(c)7 • $500k-$1M nonprofits • Source year 2012

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2012

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2012

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2012

Assets

$754,260

No earlier filing loaded for comparison.

Net Assets

$397,661

No earlier filing loaded for comparison.

Liabilities

$356,599

No earlier filing loaded for comparison.

Revenue

$123,822

No earlier filing loaded for comparison.

Expenses

$110,703

No earlier filing loaded for comparison.

Net Income

$13,119

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$800K$600K$400K$200K$0Assets 2012: $754,260Liabilities 2012: $356,599Net Assets 2012: $397,6612012Assets 2013: $762,784Liabilities 2013: $348,712Net Assets 2013: $414,0722013Assets 2014: $656,210Liabilities 2014: $341,292Net Assets 2014: $314,9182014Assets 2015: $646,561Liabilities 2015: $327,989Net Assets 2015: $318,5722015Assets 2016: $636,915Liabilities 2016: $311,797Net Assets 2016: $325,1182016Assets 2017: $644,798Liabilities 2017: $294,819Net Assets 2017: $349,9792017Assets 2018: $634,968Liabilities 2018: $277,537Net Assets 2018: $357,4312018Assets 2019: $615,280Liabilities 2019: $263,354Net Assets 2019: $351,9262019Assets 2020: $625,771Liabilities 2020: $0Net Assets 2020: $625,7712020Assets 2021: $625,771Liabilities 2021: $0Net Assets 2021: $625,7712021Assets 2022: $616,554Liabilities 2022: $192,034Net Assets 2022: $424,5202022Assets 2023: $595,946Liabilities 2023: $170,742Net Assets 2023: $425,2042023Assets 2024: $592,817Liabilities 2024: $152,252Net Assets 2024: $440,5652024

Highlighted filing

2012

Assets$754,260
Liabilities$356,599
Net Assets$397,661

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$150K$100K$50K$0-$50KRevenue 2012: $123,822Expenses 2012: $110,703Net Income 2012: $13,1192012Revenue 2013: $121,055Expenses 2013: $104,644Net Income 2013: $16,4112013Revenue 2014: $115,622Expenses 2014: $87,471Net Income 2014: $28,1512014Revenue 2015: $60,341Expenses 2015: $86,134Net Income 2015: -$25,7932015Revenue 2016: $39,839Expenses 2016: $28,676Net Income 2016: $11,1632016Revenue 2017: $39,736Expenses 2017: $34,447Net Income 2017: $5,2892017Revenue 2018: $39,054Expenses 2018: $46,877Net Income 2018: -$7,8232018Revenue 2019: $59,938Expenses 2019: $64,993Net Income 2019: -$5,0552019Revenue 2020: $16,374Expenses 2020: $33,372Net Income 2020: -$16,9982020Revenue 2021: $23,445Expenses 2021: $25,588Net Income 2021: -$2,1432021Revenue 2022: $27,530Expenses 2022: $36,747Net Income 2022: -$9,2172022Revenue 2023: $51,595Expenses 2023: $50,911Net Income 2023: $6842023Revenue 2024: $41,323Expenses 2024: $25,962Net Income 2024: $15,3612024

Highlighted filing

2012

Revenue$123,822
Expenses$110,703
Net Income$13,119
Filing Detail Status

This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2012 to Dec 31, 2012
Mission and Program Overview

Mission

To further the advancement of the profession of pharmacy educationally, fraternally, and socially.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings